Novo Nordisk’s diabetes medicine Rybelsus, an oral form of the GLP-1 drug semaglutide, provides similar cardiovascular ...

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Chronic kidney disease (CKD) is defined as a progressive ... and the decline in glomerular filtration rate. The most severe form is end-stage renal disease. Based on genome-wide association ...